Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRRT cessation timing guided by furosemide stress test in severe acute kidney injury
ChiCTR2400091040Phase 4Completed
- Sponsor
- Zhejiang Provincial People's Hospital
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of furosemide in acute kidney failure (AKF) (2 arms), sponsored by Zhejiang Provincial People's Hospital. Primary endpoint: Weaning success rate. Started Oct 2024; status: completed.
02
Drugs
furosemide
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on ChiCTR2400091040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091040.